{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:24:52Z","timestamp":1790717092830,"version":"4.1.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/br.2017.860","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T06:27:25Z","timestamp":1487312845000},"page":"401-410","source":"Crossref","is-referenced-by-count":24,"title":["Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype"],"prefix":"10.3892","volume":"6","author":[{"given":"Zhi-Zhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"key20180107142716_b1-br-0-0-860","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107142716_b2-br-0-0-860","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jgh.12164","article-title":"Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study","volume":"28","author":"Zeng","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107142716_b3-br-0-0-860","first-page":"1839","article-title":"First prospective, population-based inflammatory bowel disease incidence study in mainland of China: The emergence of \u2018western\u2019 disease","volume":"19","author":"Zhao","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107142716_b4-br-0-0-860","doi-asserted-by":"crossref","first-page":"e101296","DOI":"10.1371\/journal.pone.0101296","article-title":"The incidence of inflammatory bowel disease in Northern China: A prospective population-based study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"key20180107142716_b5-br-0-0-860","doi-asserted-by":"crossref","first-page":"296470","DOI":"10.1155\/2013\/296470","article-title":"Review of inflammatory bowel disease in China","volume":"2013","author":"Ye","year":"2013","journal-title":"Sci World J"},{"key":"key20180107142716_b6-br-0-0-860","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3810\/pgm.2010.07.2184","article-title":"Serologic markers: Impact on early diagnosis and disease stratification in inflammatory bowel disease","volume":"122","author":"Arai","year":"2010","journal-title":"Postgrad Med"},{"key":"key20180107142716_b7-br-0-0-860","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"key20180107142716_b8-br-0-0-860","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National cooperative Crohn's disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"key20180107142716_b9-br-0-0-860","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.297.6656.1105","article-title":"Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease","volume":"297","author":"Main","year":"1988","journal-title":"BMJ"},{"key":"key20180107142716_b10-br-0-0-860","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/ibd.20226","article-title":"IBD serological panels: Facts and perspectives","volume":"13","author":"Peyrin-Biroulet","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107142716_b11-br-0-0-860","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0171-2985(11)80509-7","article-title":"A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease","volume":"181","author":"Rump","year":"1990","journal-title":"Immunobiology"},{"key":"key20180107142716_b12-br-0-0-860","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s10350-004-6361-3","article-title":"Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease","volume":"45","author":"Kim","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"key20180107142716_b13-br-0-0-860","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cca.2010.05.041","article-title":"The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China","volume":"411","author":"Zhou","year":"2010","journal-title":"Clin Chim Acta"},{"key":"key20180107142716_b14-br-0-0-860","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1572-0241.2004.40486.x","article-title":"A prospective comparative study of ASCA and pANCA in Chinese and caucasian IBD patients","volume":"99","author":"Lawrance","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key20180107142716_b15-br-0-0-860","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOG.0000000000000076","article-title":"Serological studies in inflammatory bowel disease: How important are they?","volume":"30","author":"Papp","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"key20180107142716_b16-br-0-0-860","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology"},{"key":"key20180107142716_b17-br-0-0-860","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: A prospective follow-up study","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"key":"key20180107142716_b18-br-0-0-860","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10620-006-9527-0","article-title":"Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis","volume":"52","author":"Makharia","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key20180107142716_b19-br-0-0-860","first-page":"39","article-title":"Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease","volume":"21","author":"Gologan","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"key":"key20180107142716_b20-br-0-0-860","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1572-0241.2004.40369.x","article-title":"Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype","volume":"99","author":"Zholudev","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key20180107142716_b21-br-0-0-860","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key20180107142716_b22-br-0-0-860","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s10620-012-2244-y","article-title":"Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: A meta-analysis","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key20180107142716_b23-br-0-0-860","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: A systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107142716_b24-br-0-0-860","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease","volume":"128","author":"Targan","year":"2005","journal-title":"Gastroenterology"},{"key":"key20180107142716_b25-br-0-0-860","doi-asserted-by":"crossref","first-page":"28","DOI":"10.11613\/BM.2013.006","article-title":"Serological markers of inflammatory bowel disease","volume":"23","author":"Kuna","year":"2013","journal-title":"Biochem Med (Zagreb)"},{"key":"key20180107142716_b26-br-0-0-860","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4291\/wjgp.v6.i1.13","article-title":"Laboratory markers in ulcerative colitis: Current insights and future advances","volume":"6","author":"Cioffi","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"key20180107142716_b27-br-0-0-860","first-page":"15","article-title":"Anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel diseases","volume":"3","author":"Wang","year":"2000","journal-title":"Chin J Integr Med"},{"key":"key20180107142716_b28-br-0-0-860","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"key20180107142716_b29-br-0-0-860","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ibd.20292","article-title":"Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD. Inflamm","volume":"14","author":"Devlin","year":"2008","journal-title":"Bowel Dis"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2017.860\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T16:35:12Z","timestamp":1568824512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,17]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/br.2017.860"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.860","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}